-
-
-
-
-
-
-
Japan's health ministry grants orphan drug status to Quoin's QRX003
-
-
-
-
-
-
-
Quoin Pharmaceuticals enrolls three patients in Netherton Syndrome study
-
-
-
-
-
-
-
Quoin Pharmaceuticals (QNRX) Regains Compliance with Nasdaq Minimum Bid Price Rule
-
-
-
-
-
-
-
Quoin Pharmaceuticals (QNRX) Announces Pricing of $6.8 Million Public Offering
-
-
-
-
-
479,044 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


